CERRITOS, CA -- (Marketwired - Apr 7, 2015) - Millennium Dental Technologies, Inc. (MDT) has announced a new partnership with Rutgers School of Dental Medicine in Newark, New Jersey. This written agreement, signed by Kathleen Bramwell, MBA, Senior Vice Chancellor, Finance and Administration, ensures that upon graduation, periodontal residents will already be trained in the LANAP® and LAPIP™ protocols.
Three Rutgers University professors, Andrew Sullivan, DDS - Director of Postgraduate Periodontics and Interim Chairman; Howard Drew, DMD - Clinical Professor of Periodontics, Director of Implantology, and Vice Chairman of the Department of Periodontics; and Joel Pascuzzi, DMD, FIDC, FADC - Clinical Professor of Periodontics and the Director of the Pre-Doctorate Periodontal Program, completed training with the Institute for Advanced Laser Dentistry (IALD) in Cerritos, California, in February 2015. Affectionately referred to as Laser BootCamp®, the IALD training is a live-patient, clinical, hands-on course on the PerioLase® MVP-7™ and the LANAP® and LAPIP™ protocols. Following the initial Rutgers University site visit, MDT and IALD personnel visited Rutgers University to help familiarize the dental assistants, hygienists, and residents with the LANAP® and LAPIP™ protocols and proper care of their new PerioLase® MVP-7™.
Millennium, which is also developing a partnership with the US Army, has plans to continue building relationships with other educational institutions as well. "Rutgers is helping to lead the way for academic institutions to provide advanced periodontal disease treatment that patients will accept," stated Dawn M. Gregg, DDS, IALD CEO and training director. "Bringing the PerioLase® MVP-7™ for the LANAP® and LAPIP™ protocols to the Rutgers University postgraduate periodontal program advances the standard of care for treating periodontitis and peri-implantitis."
Professor and Chair, Dr. Andrew Sullivan says, "We can't lag behind in our profession. It is important for our periodontal residents to graduate on the leading edge, having been trained on the most advanced, evidence-based periodontal disease treatments available. Of additional benefit is having access to a solution to the growing number of ailing and failing implants and for treating other dental maladies using the PerioLase® MVP-7™."
The LANAP® protocol with the PerioLase® MVP-7™ is the only US FDA-cleared laser periodontitis treatment with any scientific evidence of regenerating the periodontal ligament attachment to the root surface and a new root coating (cementum). In addition, there are over 400 published positive patient outcomes and two histology studies. The human histology research proves the LANAP® protocol creates cementum-mediated periodontal new attachment to the root surface in the absence of long junctional epithelium. Patients experience little to no postoperative discomfort because the procedure requires no use of scalpels or the placement of sutures, allowing for faster, easier recovery. Of significant note, according to a recent systematic review by the American Academy of Periodontology's Regeneration Workshop, the LANAP® protocol "may offer advantages in regeneration of defects in the esthetic zone in which minimal soft tissue change is required." The PerioLase® MVP-7™ is also developed for the LAPIP™ protocol, for the minimally invasive surgical treatment for peri-implantitis and mucositis around ailing and failing implants.
 Periodontal Regeneration - Intrabony Defects: A Systematic Review From the AAP Regeneration Workshop - J Periodontol. February 2015 (2 Suppl) Richard T. Kao, DDS, PhD, Salvador Nares, DDS, PhD, and Mark A. Reynolds, DDS, PhD, MA, page S82.